Trial Details
COMPLETEDBasic Information
| Clinical ID | c2665 |
|---|---|
| Identifier | NCT03142321 |
| Trial Title | Defining Predictors of RT Response to Vedolizumab in IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease of Small Intestine |
| Interventions | DRUG: Vedolizumab 300 MG Injection [Entyvio] |
Participant Information
| Sponsor | Washington University School of Medicine |
|---|---|
| City | St Louis |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2018-06-08 |
|---|---|
| Primary Completion Date | 2024-05-22 |
| Completion Date | 2024-10-28 |